Literature DB >> 26766307

Pre-birth cohort study of atopic dermatitis and severe bronchiolitis during infancy.

Diana S Balekian1,2, Rachel W Linnemann2,3, Victor M Castro4,5, Roy Perlis6,7, Ravi Thadhani2,8, Carlos A Camargo1,2,9.   

Abstract

BACKGROUND: Infants hospitalized for bronchiolitis (i.e. severe bronchiolitis) are at increased risk of childhood asthma. There are many known risk factors for severe bronchiolitis, including cardiac and pulmonary diseases. Less is known about the association between atopic diseases and risk of severe bronchiolitis. We sought to further examine risk factors for severe bronchiolitis, focusing on atopic dermatitis (AD).
METHODS: We conducted a nested cohort study within the Massachusetts General Hospital Obstetric Maternal Study (MOMS), a prospective cohort of pregnant women enrolled during 1998-2006. Children of mothers enrolled in MOMS were included in the analysis if they received care within our health system (n = 5407). Potential risk factors for bronchiolitis and hospitalization data were extracted from the children's electronic health records; we also examined pregnancy and perinatal risk factors collected from the underlying MOMS data.
RESULTS: During the first year of life, 125 infants (2.3%) had severe bronchiolitis. Eighteen of these patients had AD; 11 (61%) were diagnosed with AD prior to bronchiolitis hospitalization. In unadjusted analyses, AD was associated with severe bronchiolitis (χ(2) 14.6; p < 0.001). In multivariable analyses adjusting for nine known risk factors for severe bronchiolitis, including demographics, birth season, disposition at birth, cardiac disease, maternal parity, and delivery mode, AD was associated with increased odds of severe bronchiolitis (odds ratio 2.72, 95% confidence interval 1.60-4.63).
CONCLUSIONS: Atopic dermatitis is significantly associated with severe bronchiolitis in infancy. The mechanism of the AD-bronchiolitis association is unclear and merits further study; this research may shed light on the pathogenesis of asthma.
© 2016 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  asthma; atopic dermatitis; birth season; bronchiolitis; congenital heart disease; eczema; respiratory syncytial virus; risk factors

Mesh:

Year:  2016        PMID: 26766307     DOI: 10.1111/pai.12532

Source DB:  PubMed          Journal:  Pediatr Allergy Immunol        ISSN: 0905-6157            Impact factor:   6.377


  5 in total

1.  Increased synapse elimination by microglia in schizophrenia patient-derived models of synaptic pruning.

Authors:  Carl M Sellgren; Jessica Gracias; Bradley Watmuff; Jonathan D Biag; Jessica M Thanos; Paul B Whittredge; Ting Fu; Kathleen Worringer; Hannah E Brown; Jennifer Wang; Ajamete Kaykas; Rakesh Karmacharya; Carleton P Goold; Steven D Sheridan; Roy H Perlis
Journal:  Nat Neurosci       Date:  2019-02-04       Impact factor: 24.884

2.  Respiratory health, allergies, and the farm environment: design, methods and enrollment in the observational Wisconsin Infant Study Cohort (WISC): a research proposal.

Authors:  Christine M Seroogy; Jeffrey J VanWormer; Brent F Olson; Michael D Evans; Tara Johnson; Deanna Cole; Kathrine L Barnes; Tamara Kronenwetter Koepel; Amy Dresen; Jennifer Meece; Ronald E Gangnon; Matthew C Keifer; Casper G Bendixsen; James E Gern
Journal:  BMC Res Notes       Date:  2019-07-16

3.  A comparison of case definitions for infant atopic dermatitis in a multicenter prospective cohort study.

Authors:  David X Zheng; Ruth J Geller; Lacey B Robinson; Markus D Boos; Carlos A Camargo
Journal:  Health Sci Rep       Date:  2021-07-12

Review 4.  Prediction and prevention of allergy and asthma in EAACI journals (2016).

Authors:  Jean Bousquet; Clive Grattan; Thomas Bieber; Paolo Matricardi; Hans Uwe Simon; Ulrich Wahn; Antonella Muraro; Peter W Hellings; Ioana Agache
Journal:  Clin Transl Allergy       Date:  2017-12-02       Impact factor: 5.871

5.  RSV-hRV co-infection is a risk factor for recurrent bronchial obstruction and early sensitization 3 years after bronchiolitis.

Authors:  Flore Amat; Chloé Plantard; Aurélien Mulliez; Isabelle Petit; Emmanuelle Rochette; Matthieu Verdan; Cécile Henquell; Guillaume Labbé; Marie Christine Heraud; Bertrand Evrard; André Labbé
Journal:  J Med Virol       Date:  2018-02-15       Impact factor: 2.327

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.